Betadine Solution

Natural health product licensed in Canada

Licence holder: iNova Pharmaceuticals (Australia) Pty Limited
NPN or DIN-HM: 00158348
Status: Active licence
Licence date: 16 November 2009
Revision date: 7 January 2025
Form: Solution
Route of administration: Topique
Application type: DIN de transition

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and source	Per dosage unit, according to the source
Povidone iodée Source : Synthétique Potency : 1 % Iodine	10 %

Medicinal ingredient and source

Per dosage unit, according to the source

Povidone iodée

Source : Synthétique

Potency : 1 % Iodine

10 %

Non-medicinal ingredients

Glycérine, Eau purifiée, Pareth-25-9, Acid citrique, Phosphate de disodium anhydre, Acide citrique anhydre, Hydroxyde de sodium

Recommended doses in Canada

Population	Age	Quantity per serving	Frequency
Sous-population S/O	Not specified	Not specified	Not specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Film-forming, non-staining and water-soluble. Dependable microbicide for situations such as: ¿ pre-operative skin preparation of the operative site ¿ disinfection of wounds, skin, genital and oropharangeal mucosa ¿ anti-infective prophylaxis during hospital and office procedures (i.e., injections) For topical use only. Use full strength for pre- and post-operative skin and mucus membrane antisepsis, prophylaxis and treatment of wounds, lacerations and burns, bacterial and mycotic infections of the skin, trichomonal, monilial and non-specific vaginitis, cervicitis, oral infections and dental procedures.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.